These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 373792)
1. A randomized double-blind trial of two low dose combined oral contraceptives. Bounds W; Vessey M; Wiggins P Br J Obstet Gynaecol; 1979 Apr; 86(4):325-9. PubMed ID: 373792 [TBL] [Abstract][Full Text] [Related]
2. A randomized, double-blind study of two combined and two progestogen-only oral contraceptives. Sheth A; Jain U; Sharma S; Adatia A; Patankar S; Andolsek L; Pretnar-Darovec A; Belsey MA; Hall PE; Parker RA; Ayeni S; Pinol A; Li Hoi Foo C Contraception; 1982 Mar; 25(3):243-52. PubMed ID: 6804162 [TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind study of six combined oral contraceptives. Contraception; 1982 Mar; 25(3):231-41. PubMed ID: 6804161 [TBL] [Abstract][Full Text] [Related]
4. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol. Akerlund M; Røde A; Westergaard J Br J Obstet Gynaecol; 1993 Sep; 100(9):832-8. PubMed ID: 8218004 [TBL] [Abstract][Full Text] [Related]
5. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen. Wilson ES; Cruickshank J; McMaster M; Weir RJ Br J Obstet Gynaecol; 1984 Dec; 91(12):1254-60. PubMed ID: 6440589 [TBL] [Abstract][Full Text] [Related]
6. Comparison of contraceptive acceptability of levonorgestrel and ethinyl oestradiol administered in one three-phasic (Trionetta) and one monophasic (Neovletta) version. Carlborg L Contraception; 1983 May; 27(5):439-52. PubMed ID: 6349925 [TBL] [Abstract][Full Text] [Related]
7. A double-blind comparison of the efficacy and acceptability of Femodene and Microgynon-30. Loudon NB; Kirkman RJ; Dewsbury JA Eur J Obstet Gynecol Reprod Biol; 1990 Mar; 34(3):257-66. PubMed ID: 2178992 [TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind study of two combined oral contraceptives containing the same progestogen, but different estrogens. World Health Organization Task Force on Oral Contraception. Contraception; 1980 May; 21(5):445-59. PubMed ID: 7428356 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of the clinical performance of three triphasic oral contraceptives: a multicenter, randomized comparative trial. Schilling LH; Bolding OT; Chenault CB; Chong AP; Fleury F; Forrest K; Glick HI; Hasson HM; Heil CG; London RS Am J Obstet Gynecol; 1989 May; 160(5 Pt 2):1264-8. PubMed ID: 2655451 [TBL] [Abstract][Full Text] [Related]
10. A comparative study of two low-dose combined oral contraceptives: results from a multicenter trial. Dunson TR; McLaurin VL; Israngkura B; Leelapattana B; Mukherjee R; Perez-Palacios G; Saleh AA Contraception; 1993 Aug; 48(2):109-19. PubMed ID: 8403908 [TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind, placebo-controlled comparison of the impact of low-dose and triphasic oral contraceptives on follicular development. Young RL; Snabes MC; Frank ML; Reilly M Am J Obstet Gynecol; 1992 Sep; 167(3):678-82. PubMed ID: 1530022 [TBL] [Abstract][Full Text] [Related]
12. A multicenter comparative trial of triphasic and monophasic, low-dose combined oral contraceptives. Dunson TR; McLaurin VL; Aguayo EL; de Silva P; Calventi V; Gerais AS; Serani RG Contraception; 1993 Jun; 47(6):515-25. PubMed ID: 8334888 [TBL] [Abstract][Full Text] [Related]
13. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial. Notelovitz M; Kitchens CS; Khan FY Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974 [TBL] [Abstract][Full Text] [Related]
14. A comparative study of Norinyl 1/35 versus Lo-Ovral in Ile-Ife Nigeria. Ayangade O; Akinyemi A Int J Gynaecol Obstet; 1989 Oct; 30(2):165-70. PubMed ID: 2572488 [TBL] [Abstract][Full Text] [Related]
15. The 150/30 formulation. Experience in the United Kingdom. Guillebaud J J Reprod Med; 1983 Jan; 28(1 Suppl):66-70. PubMed ID: 6403702 [TBL] [Abstract][Full Text] [Related]
16. Comparison of a novel norgestimate/ethinyl estradiol oral contraceptive (Ortho Tri-Cyclen Lo) with the oral contraceptive Loestrin Fe 1/20. Hampton RM; Short M; Bieber E; Bouchard C; Ayotte N; Shangold G; Fisher AC; Creasy GW Contraception; 2001 Jun; 63(6):289-95. PubMed ID: 11672549 [TBL] [Abstract][Full Text] [Related]
17. Cycle control, tolerability, and satisfaction among women switching from 30-35 microg ethinyl estradiol-containing oral contraceptives to the triphasic norgestimate/25 microg ethinyl estradiol-containing oral contraceptive Ortho Tri-Cyclen LO. Poindexter AN; Burkman R; Fisher AC; LaGuardia KD Int J Fertil Womens Med; 2003; 48(4):163-72. PubMed ID: 13677549 [TBL] [Abstract][Full Text] [Related]
18. Control of fertility with oral medication. Diddle AW; Watts GF; Gardner WH; Williamson PJ West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556 [TBL] [Abstract][Full Text] [Related]
19. An investigation into the effect of tenidap sodium on the pharmacokinetics of a combined oral contraceptive. Coates PE; Mesure R Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):47S-50S. PubMed ID: 7547095 [TBL] [Abstract][Full Text] [Related]
20. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring. Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]